A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects with Parkinson's Disease

Recruiting

Phase 1

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects with Parkinson's Disease

Sponsor:

Sumitomo Pharma America, Inc.

Code:

NCT06753331

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 40 - 69

Healthy Volunteers: Not accepted

Interventions

DSP-1083 implantation

Sham surgery treatment

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information